Paracetamol API
$0.10 bnAnnual import
25%Indian capability
6,050Supplier concentration (HHI)
₹600 crTo localise
Why India imports it. China dominates KSM for paracetamol; India has capacity at Malladi and KPL.
Why it matters. Most-consumed analgesic in India.
Can India localise it? Yes - 2-3 years; KSM is the gap.
Where it comes from. China (75%), India (20%), Germany (5%).
Scorecard
The ten indices
CMDI 67Dependency
LPI 60.75Localisation potential
IAI 66.25Investment attractiveness
SRI 72.25Supply risk
SCI 50Supply-chain complexity
TRI 40.5Technology readiness
IMI 66.5Industrial multiplier
NSRI 58.25National-security relevance
EPI 65.25Export potential
ICGI 59.75Capability gap
Who makes it
Manufacturers
In India
Malladi Drugs & PharmaceuticalsKpl International
Global leaders
Huaheng ChemicalAnqiu Lu'An
Intelligence
Related signals
Sources
Primary references
Confidence: Verified. Verified: PLI for APIs documented. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).